
NICE has published draft guidance which does not recommend Stelara (ustekinumab) for treating moderately to severely active ulcerative colitis in …

A team of biomedical scientists at the University of California has found that a FDA-approved drug for treating rheumatoid arthritis …

Death rates for breast, bowel, lung and prostate cancer combined have fallen by almost a third in the last 20 …

When French pharmaceutical company Sanofi announced the appointment of Dr Anne Beal as chief patient officer in late March, the …
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board

